InvestorsHub Logo
Followers 47
Posts 696
Boards Moderated 0
Alias Born 05/12/2017

Re: flipper44 post# 436450

Wednesday, 01/19/2022 9:25:38 AM

Wednesday, January 19, 2022 9:25:38 AM

Post# of 692405
Nice recap flipper44!

Every time someone talks about a buy-out I think about this sort of thing. Yeah, the big pharmaceutical companies have money and expertise. They can push through to approval. They have the management expertise to run the company after approval. But they are NOT in the business of personalized therapies. They are in the business of shots and pills. Mass produce, mass market, sell as much as you can regardless of need, efficacy, or side effects.

You need look no farther than the Oxy market to see how this all plays out. If BP bought NWBO earlier what would be their incentive to get it across the finish line and create a new Standard of Care? They can make far more money far more easily with patients getting radiation, chemo and a bunch of useless treatments, and treatments to help mitigate or mask the side-effects of those treatments, than they could by actually curing people.

The longer NWBO holds out and the farther they make it on their own, the more money BP will need to shell out and the harder it will be to bury DC-Vax in the Closet of Actual Effectiveness.

So yeah, maybe we could all be using our $5-$10 per share buyout money right now and wonder why no one ever hears about that dendric cell vaccine that had so much promise. Or, maybe we get to be part of financing an actual cure for cancer and walk away with a much higher amount per share in the coming months.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News